You can buy or sell Walgreens and other stocks, options, ETFs, and crypto commission-free!
Walgreens Boots Alliance, Inc. engages in the provision of drug store services. The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. Read More The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses, which sells its products under brand names Walgreens and Duane Reade. The Retail Pharmacy International segment offers retail stores, which sells products of brands No7, Boots Pharmaceuticals, Botanics, Liz Earle, and Soap & Glory. The Pharmaceutical Wholesale segment supplies medicines, other healthcare products and related services to pharmacies, doctors, health centers, and hospitals. The company was founded in 1901 and is headquartered in Deerfield, IL.
52 Week High
52 Week Low
Bill & Melinda Gates Foundation Trust Sells Off Slumping Walgreens Stock
Text size The Bill & Melinda Gates Foundation Trust has sold all of its Walgreens Boots Alliance stock. The trust, which administers the assets of the eponymous foundation, disclosed Wednesday in a form it filed with the Securities and Exchange Commission that as of the end of the first quarter, it no longer owned any Walgreens stock (ticker: WBA). At the end of 2018, the trust had owned 3.5 million shares of the drugstore and pharmacy chain. Editor's Choice Walgreens stock hasn’t been having an easy ti...
RayJay: Walgreens Could Acquire Drug Distributor AmerisourceBergen
Given the climate of mergers and acquisitions within the pharmacy space in recent years, Walgreens Boots Alliance Inc (NYSE: WBA) has been quiet on the merger front.
Seeking AlphaMay 14
AmerisourceBergen up 2% on analyst note on takeover thesis
Drug wholesaler AmerisourceBergen (ABC +1.7% ) is up on average volume in apparent response to a note from Raymond James analyst John Ransom that it could be a potential acquisition target by Walgreens Boot Alliance (WBA +1.7% ) considering the latter's lack of recent deals and its 27% stake in ABC. He also mentions LabCorp (LH +2% ) as another enticing target, offering more upside than ABC with lower risk (opioid-related litigation) but with less financial benefit. WBA is in a joint venture with the lab s...
$1.74 per share
$1.64 per share